This response, which takes place in human and mouse cancers, depends on activation of nuclear factor kappa B (NF-κB) and nuclear translocation of the closely related histone (and lysine) acetyltransferases p300 and CREB binding protein (CBP). Here, NFKB1 is linked to cancer.